18 sep
|
Alexion
|
Barcelona
Alexion, AstraZeneca Rare Disease, seeks a Director to lead general value access, pricing, and reimbursement for Haematology indications, with a focus on PNH and HSCT‑TMA. You will drive evidence-based value propositions and collaborate with GMMA and country teams to optimize patient access.
The role requires leadership across cross-functional teams, HTA expertise, and a proven track record in global payer environments.
#J-18808-Ljbffr
📌 Global Haematology Pricing & Access Lead (Barcelona)
🏢 Alexion
📍 Barcelona